Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13406
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Horthongkham N. | |
dc.contributor.author | Athipanyasilp N. | |
dc.contributor.author | Pattama A. | |
dc.contributor.author | Kaewnapan B. | |
dc.contributor.author | Sornprasert S. | |
dc.contributor.author | Srisurapanont S. | |
dc.contributor.author | Kantakamalakul W. | |
dc.contributor.author | Amaranond P. | |
dc.contributor.author | Sutthent R. | |
dc.date.accessioned | 2021-04-05T03:23:44Z | - |
dc.date.available | 2021-04-05T03:23:44Z | - |
dc.date.issued | 2016 | |
dc.identifier.issn | 19326203 | |
dc.identifier.other | 2-s2.0-84978696444 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13406 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978696444&doi=10.1371%2fjournal.pone.0158244&partnerID=40&md5=695261e8353255889e2ea97b0a8f3c52 | |
dc.description.abstract | Influenza B virus, which causes acute respiratory infections, has increased in prevalence in recent years. Based on the nucleotide sequence of the hemagglutinin (HA) gene, influenza B virus can be divided into two lineages, Victoria and Yamagata, that co-circulate during the influenza season. However, analysis of the potential association between the clinical and virological characteristic and the lineage of influenza B viruses isolated in Thailand was lacking. To investigate influenza B virus genetically and determine its neuraminidase (NA) inhibitor susceptibility phenotype, a total of 6920 nasopharyngeal-wash samples were collected from patients with influenza-like illness between the years 2011 and 2014 and were screened for influenza B virus by real-time PCR. Of these samples, 3.1% (216/6920) were confirmed to contain influenza B viruses, and 110 of these influenza viruses were randomly selected for nucleotide sequence analysis of the HA and NA genes. Phylogenetic analysis of the HA sequences showed clustering into various clades: Yamagata clade 3 (11/110, 10%), Yamagata clade 2 (71/110, 64.5%), and Victoria clade 1 (28/110, 25.5%). The analysis of clinical characteristic demonstrated that the Victoria lineage was significantly associated with the duration of hospitalization, number of deceased cases, pneumonia, secondary bacterial infection and underlying disease. When combined with phylogenetic analysis of the NA sequences, four samples showed viruses with reassortant sequences between the Victoria and Yamagata lineages. Statistical analysis of the clinical outcomes and demographic data for the reassortant strains did not differ from those of the other strains in circulation. Oseltamivir-resistant influenza B viruses were not detected. Our findings indicated the co-circulation of the Victoria and Yamagata lineages over the past four cold seasons in Bangkok. We also demonstrated differences in the clinical symptoms between these lineages. © 2016 Horthongkham et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.subject | oseltamivir | |
dc.subject | virus hemagglutinin | |
dc.subject | virus sialidase | |
dc.subject | Influenza virus hemagglutinin | |
dc.subject | oseltamivir | |
dc.subject | sialidase | |
dc.subject | adolescent | |
dc.subject | aged | |
dc.subject | amino acid substitution | |
dc.subject | animal cell | |
dc.subject | antiviral resistance | |
dc.subject | Article | |
dc.subject | child | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | gene amplification | |
dc.subject | gene mutation | |
dc.subject | gene sequence | |
dc.subject | genetic variability | |
dc.subject | HA gene | |
dc.subject | human | |
dc.subject | Influenza B virus | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | mutational analysis | |
dc.subject | NA gene | |
dc.subject | newborn | |
dc.subject | nonhuman | |
dc.subject | nucleotide sequence | |
dc.subject | phylogenetic tree | |
dc.subject | phylogeny | |
dc.subject | prevalence | |
dc.subject | real time polymerase chain reaction | |
dc.subject | sequence analysis | |
dc.subject | tertiary care center | |
dc.subject | Thailand | |
dc.subject | virus detection | |
dc.subject | adult | |
dc.subject | antagonists and inhibitors | |
dc.subject | cluster analysis | |
dc.subject | dna mutational analysis | |
dc.subject | genetics | |
dc.subject | infant | |
dc.subject | Influenza, Human | |
dc.subject | middle aged | |
dc.subject | phenotype | |
dc.subject | preschool child | |
dc.subject | tertiary care center | |
dc.subject | virology | |
dc.subject | young adult | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Child | |
dc.subject | Child, Preschool | |
dc.subject | Cluster Analysis | |
dc.subject | DNA Mutational Analysis | |
dc.subject | Female | |
dc.subject | Hemagglutinin Glycoproteins, Influenza Virus | |
dc.subject | Humans | |
dc.subject | Infant | |
dc.subject | Infant, Newborn | |
dc.subject | Influenza B virus | |
dc.subject | Influenza, Human | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Neuraminidase | |
dc.subject | Oseltamivir | |
dc.subject | Phenotype | |
dc.subject | Phylogeny | |
dc.subject | Real-Time Polymerase Chain Reaction | |
dc.subject | Tertiary Care Centers | |
dc.subject | Thailand | |
dc.subject | Young Adult | |
dc.title | Epidemiological, clinical and virological characteristics of influenza B virus from patients at the hospital tertiary care units in Bangkok during 2011-2014 | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | PLoS ONE. Vol 11, No.7 (2016) | |
dc.identifier.doi | 10.1371/journal.pone.0158244 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.